Dr Thomas Exner

Dr Thomas Exner

Job Title: 
Chief Scientific Officer (CSO)

Dr Thomas Exner is responsible for the scientific planning, execution and supervision of different commercial project in the area of data management and integrated testing strategy development for risk/safety assessment of chemicals, drugs and nano materials. Additionally, he is coordinating the H2020 e-infrastructure project OpenRiskNet, is work package leader in the ACEnano and NanoCommons project, leads the creation of a knowledge infrastructure in the EU-ToxRisk project as well as functions as principal investigator in the Marie Skłodowska-Curie Innovative Training Network in3.

He studied chemistry and did his PhD in physical chemistry at the Technische Universität Darmstadt. After a postdoctoral stay at the University of Saskatchewan, Canada, he was appointed Assistant Professor at the University of Konstanz in 2003. In April 2012, he moved to the Institute of Pharmacy at the University of Tübingen and continued his research in close co-operation with the experimental and theoretical groups at the Institute until early 2015, when he moved to Douglas Connect.

Dr. Exner is the author and co-author of more than 50 articles in peer reviewed international journals and several other scientific contributions.

Latest Tweets

Edelweiss Connect (2 weeks ago)
RT @barryhardy: Cosmetics Assessment is an area with a strong need for use of non-animal testing methods and continuing innovation in testi…
Edelweiss Connect (2 weeks ago)
RT @barryhardy: Discussion of COVID-19 work using modelling and informatics 19 CEST, Tuesday 22 September, OpenTox 2020 virtual conference…
Edelweiss Connect (2 weeks ago)
Join us for the 2020 OpenTox Virtual Conference Sep 21-25 The OpenTox 2020 Conference activity will be supported b… https://t.co/azV6JH5sJI
Edelweiss Connect (2 months ago)
#SaferWorldbyDesign Use of alternative skin models for animal-free safety and efficacy testing in dermatology resea… https://t.co/I9wkhBRjZm
Edelweiss Connect (2 months ago)
RT @barryhardy: The activities of drug inactive ingredients on biological targets This #OpenTox Webinar (Thursday 8 August) will include a…

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA